BioCentury
ARTICLE | Regulation

Discounting patents

April 11, 2005 7:00 AM UTC

Innovation on Trial

As part of the German government’s efforts to cut drug prices, it increased the power of the Gemeinsame Bundesausschuss (G-BA, Joint Federal Committee) in January 2004. The goal is to bring more patented drugs into the mandatory discounting scheme required of generics...